Hydrochloric Acid → HCID 23081597, compound
Reaction equation
[CH3:1][C:2]1([CH2:13][N:14]2[CH2:19][CH2:18][N:17]([C:20]([O:22][CH2:23][C:24]3[CH:29]=[CH:28][C:27]([C:30](OC)([O:32]C)[CH3:31])=[CH:26][CH:25]=3)=[O:21])[CH2:16][CH2:15]2)[O:6][C:5]2=[N:7][C:8]([N+:10]([O-:12])=[O:11])=[CH:9][N:4]2[CH2:3]1.Cl.C(=O)([O-])O.[Na+]>C1COCC1>[CH3:1][C:2]1([CH2:13][N:14]2[CH2:15][CH2:16][N:17]([C:20]([O:22][CH2:23][C:24]3[CH:25]=[CH:26][C:27]([C:30](=[O:32])[CH3:31])=[CH:28][CH:29]=3)=[O:21])[CH2:18][CH2:19]2)[O:6][C:5]2=[N:7][C:8]([N+:10]([O-:12])=[O:11])=[CH:9][N:4]2[CH2:3]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 4-(1,1-dimethoxyethyl)benzyl 4-(2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl)piperazine-1-carboxylate (600 mg, 1.23 mmol), 1 N hydrochloric acid (10 ml, 10 mmol) and THF (15 ml) was stirred at room temperature for 2 hours, then neutralized with a saturated sodium hydrogencarbonate solution, and the resulting mixture was extracted with ethyl acetate. The oranic phase was washed with water and then with a saturated saline solution, dried over magnesium sulfate and then filtered. The filtrate was concentrated under reduced pressure. To the residue, diethyl ether was added, and the precipitates were filtered off to afford 4-acetylbenzyl 4-(2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-ylmethyl)piperazine-1-carboxylate (558 mg, yield 99%) as a white powder.
Workup
- extractionthe resulting mixture was extracted with ethyl acetate
- washThe oranic phase was washed with water
- dry with materialwith a saturated saline solution, dried over magnesium sulfate
- filtrationfiltered
- concentrationThe filtrate was concentrated under reduced pressure
- additionTo the residue, diethyl ether was added
- filtrationthe precipitates were filtered off
Sources & evidence
- ORD record
- ord-76f66804ceed430d8b72447516e480c5
- Source dataset
- uspto-grants-2007_08
- Patent number
- US07262212B2
Reaction notes
Loading…